Keiko Baba

1.8k total citations
32 papers, 1.3k citations indexed

About

Keiko Baba is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Keiko Baba has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Infectious Diseases. Recurrent topics in Keiko Baba's work include Influenza Virus Research Studies (7 papers), Respiratory viral infections research (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Keiko Baba is often cited by papers focused on Influenza Virus Research Studies (7 papers), Respiratory viral infections research (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Keiko Baba collaborates with scholars based in Japan, United States and Australia. Keiko Baba's co-authors include Shinya Omoto, Takao Shishido, Takeki Uehara, Hitomi Hayabuchi, Kentaro Murakami, Kazuko Ohki, Mitsuyo Yamasaki, Kazuhiro Uenishi, Hiroshi Kida and Toshiyuki Kohri and has published in prestigious journals such as Journal of Biological Chemistry, American Journal of Clinical Nutrition and Clinical Infectious Diseases.

In The Last Decade

Keiko Baba

32 papers receiving 1.3k citations

Peers

Keiko Baba
Carmen Pheiffer South Africa
Abdo Jurjus Lebanon
Jain Chung United States
Geoffrey Warhurst United Kingdom
Bruce Burnett United States
Ingo Meyer Germany
Jennifer Norman United States
Carmen Pheiffer South Africa
Keiko Baba
Citations per year, relative to Keiko Baba Keiko Baba (= 1×) peers Carmen Pheiffer

Countries citing papers authored by Keiko Baba

Since Specialization
Citations

This map shows the geographic impact of Keiko Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Baba more than expected).

Fields of papers citing papers by Keiko Baba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Baba. The network helps show where Keiko Baba may publish in the future.

Co-authorship network of co-authors of Keiko Baba

This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Baba. A scholar is included among the top collaborators of Keiko Baba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Baba. Keiko Baba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uehara, Takeki, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.. (2025). Ensitrelvir treatment–emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial. Antiviral Research. 236. 106097–106097. 1 indexed citations
2.
Nobori, Haruaki, Keiko Baba, Takayuki Kuroda, et al.. (2024). Prophylactic effect of ensitrelvir in mice infected with SARS-CoV-2. Antiviral Research. 224. 105852–105852. 4 indexed citations
3.
Mukae, Hiroshi, Hiroshi Yotsuyanagi, Norio Ohmagari, et al.. (2022). Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study. Clinical Infectious Diseases. 76(8). 1403–1411. 90 indexed citations
4.
Mifsud, Edin, Steffen Wildum, Takao Shishido, et al.. (2022). Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model. Communications Biology. 5(1). 1026–1026. 7 indexed citations
5.
Lee, Leo, Jie Zhou, Rebecca Frise, et al.. (2021). Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model. PLoS Pathogens. 17(5). e1009527–e1009527. 29 indexed citations
6.
Hashimoto, Takashi, Keiko Baba, Satoshi Hata, et al.. (2020). Comprehensive assessment of amino acid substitutions in the trimeric RNA polymerase complex of influenza A virus detected in clinical trials of baloxavir marboxil. Influenza and Other Respiratory Viruses. 15(3). 389–395. 24 indexed citations
7.
Hirotsu, Nobuo, Hiroki Sakaguchi, Tôru Ishibashi, et al.. (2019). Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes. Clinical Infectious Diseases. 71(4). 971–981. 95 indexed citations
8.
Noshi, Takeshi, Mitsutaka Kitano, K. Taniguchi, et al.. (2018). In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit. Antiviral Research. 160. 109–117. 267 indexed citations
9.
Kobayashi, Satomi, Kentaro Murakami, Satoshi Sasaki, et al.. (2012). Dietary total antioxidant capacity from different assays in relation to serum C-reactive protein among young Japanese women. Nutrition Journal. 11(1). 91–91. 48 indexed citations
10.
Takatsu, Hiroyuki, Keiko Baba, Utako Kato, et al.. (2011). ATP9B, a P4-ATPase (a Putative Aminophospholipid Translocase), Localizes to the trans-Golgi Network in a CDC50 Protein-independent Manner. Journal of Biological Chemistry. 286(44). 38159–38167. 105 indexed citations
11.
Kitano, Mitsutaka, Yasushi Itoh, Makoto Kodama, et al.. (2010). Establishment of a cynomolgus macaque model of influenza B virus infection. Virology. 407(2). 178–184. 18 indexed citations
12.
Murakami, Kentaro, Satoshi Sasaki, Yoshiko Takahashi, et al.. (2008). Lower estimates of δ-5 desaturase and elongase activity are related to adverse profiles for several metabolic risk factors in young Japanese women. Nutrition Research. 28(12). 816–824. 34 indexed citations
13.
Murakami, Kentaro, Satoshi Sasaki, Yoshiko Takahashi, et al.. (2008). Total n-3 polyunsaturated fatty acid intake is inversely associated with serum C-reactive protein in young Japanese women. Nutrition Research. 28(5). 309–314. 39 indexed citations
14.
Murakami, Kentaro, Satoshi Sasaki, Yoshiko Takahashi, et al.. (2008). Dietary glycemic index is associated with decreased premenstrual symptoms in young Japanese women. Nutrition. 24(6). 554–561. 23 indexed citations
15.
Murakami, Kentaro, Satoshi Sasaki, Yoshiko Takahashi, et al.. (2007). Hardness (difficulty of chewing) of the habitual diet in relation to body mass index and waist circumference in free-living Japanese women aged 18–22 y. American Journal of Clinical Nutrition. 86(1). 206–213. 35 indexed citations
16.
Murakami, Kentaro, Satoshi Sasaki, Yoshiko Takahashi, et al.. (2007). Sensitivity and specificity of published strategies using urinary creatinine to identify incomplete 24-h urine collection. Nutrition. 24(1). 16–22. 78 indexed citations
17.
Murakami, Kentaro, Satoshi Sasaki, Kazuhiro Uenishi, et al.. (2007). Nutrient and food intake in relation to serum leptin concentration among young Japanese women. Nutrition. 23(6). 461–468. 37 indexed citations
18.
Kaida, Atsushi, Yasuo Ariumi, Keiko Baba, et al.. (2005). Identification of a novel p300-specific-associating protein, PRS1 (phosphoribosylpyrophosphate synthetase subunit 1). Biochemical Journal. 391(2). 239–247. 8 indexed citations
20.
Soeda, Takahiko & Keiko Baba. (1999). The Modification of Soy Protein on Gel Formation and It's Application for Foods.. Nippon Shokuhin Kagaku Kogaku Kaishi. 46(10). 627–632. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026